Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

Clinical trial NCT03289910 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03289910
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Atypical Chronic Myeloid Leukemia Chronic Myelomonocytic Leukemia Essential Thrombocythemia Myelodysplastic/Myeloproliferative Neoplasm Myelofibrosis Polycythemia Vera Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Start date: 2018-09-24
Primary completion: 2023-05-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.